PIERIS Pharmaceuticals GmbH

Pieris Pharmaceuticals GmbH is a subsidiary of Pieris Pharmaceutical Inc., a public US company. Pieris Pharmaceuticals GmbHis a clinical-stage biotechnology company advancing its proprietary Anticalin® technology to create differentiated drugs that are safer and more effective than conventional approaches. Exclusive to Pieris, Anticalin proteins promise to address high-unmet medical needs and expand the potential of targeted therapeutics.

 

Details


Adresse:
PIERIS Pharmaceuticals GmbH

Lise-Meitner-Straße 30
85354 Freising
Deutschland
Arbeitsgebiet:
Forschung & Lehre
Expansion:
international
Webseite:
Mitarbeiteranzahl:
11-50
Gründungsjahr:
2001